Gilman Hill Asset Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-7,366
| Closed | -$731K | – | 188 |
|
|
2019
Q3 | $731K | Sell |
7,366
-50
| -0.7% | -$4.75K | 0.24% | 96 |
|
|
2019
Q2 | $686K | Buy |
7,416
+1,165
| +19% | +$111K | 0.23% | 100 |
|
|
2019
Q1 | $590K | Sell |
6,251
-140
| -2% | -$12.2K | 0.21% | 109 |
|
|
2018
Q4 | $410K | Sell |
6,391
-605
| -9% | -$44.7K | 0.17% | 124 |
|
|
2018
Q3 | $626K | Buy |
6,996
+735
| +12% | +$65K | 0.25% | 97 |
|
|
2018
Q2 | $497K | Sell |
6,261
-540
| -8% | -$44.8K | 0.2% | 109 |
|
|
2018
Q1 | $607K | Buy |
6,801
+360
| +6% | +$34.6K | 0.27% | 94 |
|
|
2017
Q4 | $672K | Sell |
6,441
-60
| -0.9% | -$6.77K | 0.27% | 88 |
|
|
2017
Q3 | $948K | Buy |
6,501
+360
| +6% | +$49K | 0.39% | 61 |
|
|
2017
Q2 | $798K | Buy |
6,141
+355
| +6% | +$43.5K | 0.35% | 68 |
|
|
2017
Q1 | $720K | Sell |
5,786
-899
| -13% | -$108K | 0.31% | 74 |
|
|
2016
Q4 | $774K | Buy |
6,685
+1,265
| +23% | +$141K | 0.29% | 70 |
|
|
2016
Q3 | $567K | Buy |
5,420
+98
| +2% | +$10.6K | 0.22% | 82 |
|
|
2016
Q2 | $525K | Sell |
5,322
-260
| -5% | -$26.9K | 0.22% | 84 |
|
|
2016
Q1 | $559K | Buy |
5,582
+450
| +9% | +$46.3K | 0.26% | 76 |
|
|
2015
Q4 | $615K | Buy |
5,132
+335
| +7% | +$38.8K | 0.3% | 72 |
|
|
2015
Q3 | $519K | Buy |
4,797
+170
| +4% | +$21.1K | 0.27% | 77 |
|
|
2015
Q2 | $536K | Buy |
4,627
+520
| +13% | +$59.4K | 0.25% | 82 |
|
|
2015
Q1 | $473K | Buy |
4,107
+357
| +10% | +$42.7K | 0.22% | 86 |
|
|
2014
Q4 | $419K | Sell |
3,750
-371
| -9% | -$39.1K | 0.21% | 94 |
|
|
2014
Q3 | $391K | Buy |
4,121
+75
| +2% | +$6.77K | 0.21% | 95 |
|
|
2014
Q2 | $347K | Buy |
4,046
+52
| +1% | +$3.95K | 0.18% | 102 |
|
|
2014
Q1 | $279K | Buy |
3,994
+218
| +6% | +$17.3K | 0.16% | 106 |
|
|
2013
Q4 | $319K | Buy |
3,776
+86
| +2% | +$6.8K | 0.21% | 84 |
|
|
2013
Q3 | $284K | Buy |
3,690
+190
| +5% | +$13.3K | 0.2% | 81 |
|
|
2013
Q2 | $205K | Buy |
+3,500
| New | +$211K | 0.15% | 99 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Gilman Hill Asset Management's CELG Position: Q4 2019 in Review
Gilman Hill Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,366 shares — an estimated $731K sold.
Gilman Hill Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $948K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Gilman Hill Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Gilman Hill Asset Management sold 7,366 Celgene Corp shares in Q4 2019, an estimated $731K.
- Gilman Hill Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Gilman Hill Asset Management's Celgene Corp position peaked at $948K in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Gilman Hill Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.